Magnesium in PDB 6zcz: Crystal Structure of Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Ternary Complex with EY6A Fab and A Nanobody.

The structure of Crystal Structure of Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Ternary Complex with EY6A Fab and A Nanobody., PDB code: 6zcz was solved by D.Zhou, Y.Zhao, E.E.Fry, J.Ren, D.I.Stuart, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	35.26 / 2.65
Space group	H 3
Cell size a, b, c (Å), α, β, γ (°)	177.867, 177.867, 87.715, 90.00, 90.00, 120.00
R / Rfree (%)	21.5 / 26

The structure of Crystal Structure of Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Ternary Complex with EY6A Fab and A Nanobody. also contains other interesting chemical elements:

Chlorine

(Cl)

5 atoms

The binding sites of Magnesium atom in the Crystal Structure of Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Ternary Complex with EY6A Fab and A Nanobody. (pdb code 6zcz). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Crystal Structure of Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Ternary Complex with EY6A Fab and A Nanobody., PDB code: 6zcz:

Magnesium binding site 1 out of 1 in the Crystal Structure of Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Ternary Complex with EY6A Fab and A Nanobody.


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Crystal Structure of Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Ternary Complex with EY6A Fab and A Nanobody. within 5.0Å range: probe atom residue distance (Å) B Occ L:Mg302 b:69.9 occ:1.00 OG1 L:THR179 2.8 76.4 1.0 OG H:SER187 3.1 0.3 1.0 OG L:SER177 3.4 78.1 1.0 CB L:THR179 3.8 84.0 1.0 O L:SER177 3.8 77.1 1.0 CB H:SER187 4.0 94.2 1.0 CG2 H:VAL177 4.0 78.9 1.0 N H:SER187 4.4 94.0 1.0 CB L:SER163 4.5 68.4 1.0 CB L:SER177 4.5 63.9 1.0 O H:SER185 4.6 70.1 1.0 CG2 L:THR179 4.6 70.7 1.0 C L:SER177 4.7 79.8 1.0 O L:GLN161 4.7 66.1 1.0 C H:LEU186 4.8 76.8 1.0 OG H:SER185 4.8 73.6 1.0 N L:THR179 4.8 63.5 1.0 CA H:SER187 4.8 90.1 1.0 CA L:THR179 4.9 64.2 1.0 CA H:LEU186 4.9 61.3 1.0 C H:SER185 5.0 64.2 1.0

D.Zhou, H.M.E.Duyvesteyn, C.Chen, C.Huang, T.Chen, S.Shih, Y.Lin, C.Cheng, S.Cheng, Y.Huang, T.Lin, C.Ma, J.Huo, L.Carrique, T.Malinauskas, R.R.Ruza, P.N.M.Shah, T.K.Tan, P.Rijal, K.Godwin, K.Bewley, J.Tree, J.Radecke, N.G.Paterson, P.Supasa, J.Mongkolsapaya, G.R.Screaton, M.Carroll, W.James, R.J.Owens, J.Naismith, A.Townsend, E.E.Fry, Y.Zhao, J.Ren, D.I.Stuart, K.A.Huang. Structural Basis For the Neutralization of Sars-Cov-2 By An Antibody From A Convalescent Patient To Be Published.